Gene Therapy: The future is now
Gene therapy is a rapidly evolving modality enabling curative treatments for a broad range of diseases. Gene therapy aims to treat diseases by replacing, inactivating or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo). Gene therapy is one of the most exciting areas in medicine, both because of recent advances and the opportunities that are emerging.
Evotec GT - Specialised partner for gene therapy development
Evotec’s dedicated gene therapy site, Evotec GT, is located in Austria and provides a team of experts covering the full spectrum of services for end-to-end gene therapy development. Our dedicated group of scientists has long-standing experience applying their research and disease insights to various GT-related technologies and indications. Our comprehensive and combined understanding of the business, product and regulatory landscapes will guide you in developing the optimal strategy for clinical success.
Our services include the design of state-of-the-art viral AAV vectors for a diverse set of therapeutic payloads, the generation of AAV material for research and non-clinical studies, in vitro and in vivo proof of concept studies for target validation including screening of drug candidates, as well as the design, execution, and interpretation of non-clinical gene therapy studies.
Combining capabilities with our colleagues across Evotec is a great way to speed up the development of new therapies to bring to patients. At the same time, this burgeoning glimpse into a new world of technological possibilities will inspire whole new research areas that will no doubt continue to change the face of biomedical research.
What are we doing at Evotec GT
At Evotec GT, our work includes:
- Design state-of-the-art viral AAV vectors for a diverse set of therapeutic payloads
- Generation of AAV and non-viral LNP gene therapy material for research and non-clinical studies
- In vitro and in vivo studies for target validation, including screening of viral and non-viral gene therapy drug candidates
- Design, execution, and interpretation of non-clinical gene therapy studies
Evotec GT - Technical expertise
